Key points are not available for this paper at this time.
Despite improvements in treatment and oral pre-exposure prophylaxis (PrEP) access, 1. 3 million people acquired HIV in 2022. Six-monthly lenacapavir PrEP could benefit tens of millions of people at high risk of infection. However, prices are currently up to 44 819 per person per year (pppy).
Hill et al. (2024) studied this question.